Frank Landolt
Frank Landolt is Chief Counsel, Intellectual Property and Legal at Confo Therapeutics, a privately held biopharmaceutical start-up based in Ghent, Belgium specializing in GPCR-targeted therapeutics.
After studying chemistry and law at the University of Leiden in the Netherlands, Frank worked for almost ten years on pharmaceutical and biotechological patents and licensing in private practice in the Netherlands, where his clients included major pharmaceutical companies as well as some of the top biotech firms and research institutions in the Netherlands.
Prior to joining Confo in 2018, Frank worked for fifteen years in Ablynx N.V. (now a wholly owned Sanofi company), where he was a member of the management team and headed an integrated IP and legal group of four lawyers and five patent professionals. At Ablynx, Frank was involved in negotiating Ablynx’s strategic partnerships and licensing deals with AbbVie, Boehringer-Ingelheim, MSD, Merck-Serono, Novartis, Novo Nordisk, Sanofi and Wyeth.
From 2000 to 2004, Frank was director of IP and legal counsel at Devgen N.V. (now part of Syngenta), another Ghent-based biotechnology company, where he was involved in negotiating Devgen’s strategic collaborations with Sumitomo, Monsanto and DuPont Pioneer.
Frank is a Dutch and European patent attorney, and also holds a degree in business law from the University of Antwerp. He is a member of the Dutch association of patent attorneys (where he is a tutor for the professional qualification course), EPI and LES Benelux (where he is involved in the LES Licensing Course). He is a regular speaker on a range of topics relating to IP and licensing in the (bio)pharmaceutical sector. Frank was named as one of Managing IP’s ‘Corporate IP stars’ for four years in a row (2015-2018).
Andras Kupecz
Dan Roberts
Daniel has over 20 years’ experience across finance, infrastructure and renewables. He previously exited as the 2nd largest individual shareholder in infrastructure fund manager, Palisade Investment Partners ($6bn AUM across 23 businesses) and, prior to that, worked with Macquarie Capital and PwC across Sydney and London. Daniel is currently on the board of JOLT, a Blackrock-backed EV charging business where he is also the 2nd largest individual shareholder. His Bitcoin journey began in 2013/14 when he bought high and sold low and then went on to co-found Iris Energy with his brother, Will Roberts, in 2018.
Diane Adair
Clemens Heusch
Stefanie Kies
Stefan Schilling
Petri Rinkenen
Patricia Rombach
